NDC product
Diltiazem Hydrochloride
NDC 0409-4350 · Hospira, Inc.
Key facts
| Product NDC | 0409-4350 |
|---|---|
| Proprietary name | Diltiazem Hydrochloride |
| Nonproprietary name | DILTIAZEM HYDROCHLORIDE |
| Substances | DILTIAZEM HYDROCHLORIDE |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Hospira, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA075853 |
| Pharmacologic classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA] |
| Marketing start | Apr 30, 2005 |
| Marketing end | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory